The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients
Conditions: Osteoporosis; Renal Osteodystrophy; Kidney Transplant; Complications Interventions: Drug: Denosumab Inj 60 mg/ml; Other: Placebo Sponsor: Thomas Nickolas, MD MS Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Kidney Transplant | Kidney Transplantation | Orthopaedics | Osteoporosis | Research | Transplant Surgery | Transplants | Urology & Nephrology | Xgeva